{"prompt": "['Sponsor: APGD', 'ISN/Protocol 7465-CL-0301', 'EudraCT number 2017-003344-21', '- CONFIDENTIAL -', 'I.', 'SIGNATURES', '1.', \"AGREEMENT BETWEEN THE SPONSOR'S RESPONSIBLE PERSON AND\", 'THE INVESTIGATOR', 'This clinical study will be conducted in adherence to GCP, ICH Guidelines and applicable', 'laws and regulatory requirements, as well as this study protocol. As the evidence of the', 'agreement, the investigator (CHIKEN SEKININ ISHI) and responsible person of the Sponsor', '(CHIKEN IRAI SEKININSHA) inscribe in the bipartite agreement by signature or \"printed', 'name and seal\".', '14 Sep 2020', 'Astellas', 'Page 8 of 143', 'Version 4.0 Incorporating Substantial Amendment 3']['Sponsor: APGD', 'ISN/Protocol 7465-CL-0301', 'EudraCT number 2017-003344-21', '- CONFIDENTIAL -', '2.', \"SPONSOR'S SIGNATURES\", 'Required signatures (e.g., Protocol authors and contributors, etc.) are located in [Section', '15', \"Sponsor's Signatures], located at the end of this document.\", '14 Sep 2020', 'Astellas', 'Page 9 of 143', 'Version 4.0 Incorporating Substantial Amendment 3']['Sponsor: APGD', 'ISN/Protocol 7465-CL-0301', 'EudraCT number 2017-003344-21', '- CONFIDENTIAL -', '3.', \"COORDINATING INVESTIGATOR'S SIGNATURE\", \"The Coordinating Investigator's signature can be found in [Section 14\", 'Coordinating', \"Investigator's Signature].\", '14 Sep 2020', 'Astellas', 'Page 10 of 143', 'Version 4.0 Incorporating Substantial Amendment 3']\n\n###\n\n", "completion": "END"}